title: Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis.
abstract: Describe and assess the impact of a pharmacist-led patient review programme on the management and control of type 2 diabetes (T2D).
  
  
  
  Uncontrolled prospective cohort study with before and after intervention data collection.
  
  
  
  General practices within NHS Slough Clinical Commissioning Group (CCG).
  
  
  
  5910 patients with T2D.
  
  
  
  Pharmacists reviewed 5910 patients and worked with general practice teams to schedule any of the 9 key care processes recommended by the National Institute for Health and Care Excellence (NICE) that the patients were lacking, to optimise medication and to make other interventions such as providing lifestyle advice.
  
  
  
  The proportion of patients receiving the NICE-recommended 9 key care processes and proportion of patients whose glycated haemoglobin (HbA1c), blood pressure (BP) or total cholesterol (TC) readings were over target before and after the intervention period.
  
  
  
  The proportion of patients receiving all of the NICE-recommended 9 key care processes increased from 46% at project outset in April 2013 to 58% on completion in April 2014 and the percentage of patients achieving HbA1c, BP and TC targets all increased (65% to 70%, 70% to 76%, 78% to 82%, respectively). Quality Outcomes Framework (QOF) data for Slough CCG showed the percentage of diabetic patients achieving target HbA1c, BP and TC readings increased from April 2013 to April 2014, but then diminished in the year after project completion.
  
  
  
  The pharmacist-led review increased the number of key care processes administered and improved diabetic control during the year of programme delivery. The improvement abated during the year after, suggesting that such programmes should be ongoing rather than fixed term. The programme combined the strategic drive and project facilitation skills of Slough CCG, the general practice teams' knowledge of their patients and the clinical and information technology skills of an experienced pharmacist team.
authors.affiliation: NHS Slough CCG, King Edward VII Hospital, Windsor, UK.
authors.forename: Tim
authors.initials: T
authors.lastname: Langran
authors.affiliation: NHS Slough CCG, King Edward VII Hospital, Windsor, UK.
authors.forename: Nithya
authors.initials: N
authors.lastname: Nanda
authors.affiliation: Interface Clinical Services Ltd, Leeds, UK.
authors.forename: Attia
authors.initials: A
authors.lastname: Bataveljic
authors.affiliation: Interface Clinical Services Ltd, Leeds, UK.
authors.forename: Javier
authors.initials: J
authors.lastname: Gonzalez-Durio
mesh_terms: D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D003376:Counseling / Q000379:methods*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000628:therapy*; D004739:England; D006442:Glycated Hemoglobin; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D010348:Patient Care Team; D010595:Pharmacists; D015397:Program Evaluation / Q000379:methods*; D011446:Prospective Studies
chemical_list: D002784:Cholesterol; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents
keywords: PRIMARY CARE; diabetes; pharmacist